LGR4 and osteoporosis: In a previous study, treatment with mutant-type mouse RANKL (mRANKL-MT) in in vitro and in vivo osteoporosis experimental models significantly inhibited the differentiation and production of osteoclasts, which suggested a potential crosstalk between RANKL–RANK and LGR4 signaling [20].